Futura Medical Plc (FUM.L) Announced the appointment of Liberum Capital Limited ("Liberum") as its Nominated Adviser and sole Broker, with immediate effect.
RNS Number: 9076 Z Futura Medical PLC 23 May 2019 Futura Medical. Appointment of Liberum as Nominated Adviser and Broker. Futura Medical plc, a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, today announces the appointment, with immediate effect, of Liberum Capital Limited as its Nominated Adviser and...
RNS Number: 4016 Y Futura Medical PLC 08 May 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 4008 Y Futura Medical PLC 08 May 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1968 Y Futura Medical PLC 07 May 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1959 Y Futura Medical PLC 07 May 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0749 Y Futura Medical PLC 03 May 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0744 Y Futura Medical PLC 03 May 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 4096 W Futura Medical PLC 16 April 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Futura Medical Plc (FUM.L) Announced, in its final results for the year ended 31 December 2018, that its operating loss stood at £7.3 million, compared to £4.9 million. Loss after tax was £5.9 million compared to £3.9 million. The company’s diluted earnings per share was 4.46p, compared to 3.23p.
RNS Number: 6825 V Futura Medical PLC 10 April 2019 THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER ARTICLE 7 OF REGULATION NO 596/ 2014 OF THE MAR. UPON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
RNS Number: 8147 R Futura Medical PLC 05 March 2019. Futura Medical plc, a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, will announce its preliminary results for the year ended 31 December 2018 on Wednesday 10 April 2019.. James Barder, Chief Executive Officer, and Angela Hildreth, Finance...
RNS Number: 6397 Q Futura Medical PLC 20 February 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Futura Medical plc, a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, today announces that it will host its first European Key Opinion Leader Advisory Panel meeting ahead of the 21 st Congress of the ESSM on 14-16 February 2019, at Cultural and Congress Centre Cankarjev Dom, Ljubljana, Slovenia.
RNS Number: 9440 P Futura Medical PLC 13 February 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9416 P Futura Medical PLC 13 February 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9407 P Futura Medical PLC 13 February 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    204.66M

Classification

Market Indices-

Locations

HQ
Surrey Technology Centre
40 Occam Road
GU2 7YG
Guildford
Watchlist